Medical Cannabis for Epilepsy: CBD Evidence and Doses
CBD is the only cannabis compound with FDA approval for epilepsy. Epidiolex treats Dravet, Lennox-Gastaut, and tuberous sclerosis. THC has no approval.
If you are looking for the most reliable medical cannabis success stories for epilepsy, the top pick is purified cannabidiol, sold as the prescription drug Epidiolex. It is the only cannabis-derived seizure treatment approved by the U.S. Food and Drug Administration. The criteria for ranking stories here are evidence quality, regulatory review, replicable dosing, and safety reporting. Anecdotes about high-THC flower or homemade oils do not meet those criteria, even when they are moving.
A success story is more than a single patient report. The strongest stories come from controlled trials where patients, caregivers, and clinicians did not know who received the drug and who received a placebo. Weaker stories come from open-label studies, clinic chart reviews, or online posts. Those sources can still inspire hope, but they cannot show cause and effect. Seizure frequency changes on its own, and placebo responses in epilepsy trials are real.
Epidiolex is a plant-derived, purified CBD oral solution. The FDA approved it in 2018 for seizures associated with Dravet syndrome and Lennox-Gastaut syndrome, and later for tuberous sclerosis complex. This is the clearest example of a medical cannabis success story that moved from patient anecdotes to randomized trials to regulatory approval.
Use case: families with a child or adult who has treatment-resistant Dravet, Lennox-Gastaut, or tuberous sclerosis complex should ask a neurologist whether prescription CBD is appropriate.
Some patient stories describe smoking or vaping high-THC flower, or using THC-rich oils, and reporting fewer seizures. The evidence for THC alone in epilepsy is much thinner than the evidence for purified CBD. THC can cause anxiety, impaired coordination, and cognitive fog. It also can raise heart rate and interact with other drugs.
Use case: an adult with epilepsy who already uses THC for sleep or anxiety may find it helps those issues, but it should not replace a proven seizure treatment.
Many dispensaries sell CBD-dominant oils, tinctures, and edibles. These products are not the same as Epidiolex. They may contain variable amounts of CBD, THC, and other compounds. A label that says 500 mg CBD does not guarantee that the bottle holds 500 mg or that the dose is stable.
Use case: a patient who wants to try CBD outside a prescription should choose a product with a recent lab report and tell their neurologist before starting.
For the most reliable path, start with a neurologist and ask about prescription CBD. It has the strongest evidence among cannabis-derived options. For patients who use dispensary products, keep a seizure diary, use one product at a time, and avoid changing doses and strains at the same time. No cannabis product should replace emergency seizure care or a proven antiseizure medication without medical supervision.
Cannabis remains illegal under U.S. federal law, though many states allow medical use. CBD products from hemp are legal in many states but are not approved for epilepsy unless they are prescription Epidiolex. Side effects and drug interactions are real. This article is educational and is not medical advice.